Floxus Suspention

Norfloxacin
National Healthcare Pvt. Ltd.
Pack size 30ml
Dispensing mode
Source
Agent
Retail Price 55.00 NPR

Available as:

Indications

Floxus Suspention is used for: Uncomplicated urinary tract infections (including cystitis), Uncomplicated urethral and cervical gonorrhea, Prostatitis, Gastroenteritis

Adult Dose

Prostatitis Caused by susceptible strains E.coli 400 mg PO q12hr for 28-42 days UTI (Cystitis) Uncomplicated, caused by E. coli, K. pneumoniae or P. mirabilis: 400 mg PO q12hr for 3 days Uncomplicated, caused by other susceptible organisms: 400 mg PO q12hr for 7-10 days Complicated: 400 mg PO q12hr for 10-21 days Limitation-of-use: Reserve fluoroquinolones for patients who do not have other available treatment options for uncomplicated urinary tract infections Gonorrhea 800 mg PO single dose Uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae Travelers Diarrhea 400 mg PO q12hr for 3 days

Child Dose

<18 years: Safety and efficacy not established

Renal Dose

Renal impairment: CrCl (ml/min) <30 400 mg once daily

Administration

Should be taken on an empty stomach. Take on an empty stomach 1 hr before or 2 hr after meals, w/ a glass of water. Ensure adequate hydration. Do not take w/ dairy products.

Contra Indications

Hypersensitivity to quinolones; children <18 yr. Lactation.

Precautions

Patient w/ known prolongation of QT interval, uncorrected hypokalaemia, known or suspected CNS disorders (e.g. severe cerebral arteriosclerosis) or other factors that predispose to seizures. Kidney, heart or lung transplant recipients. Renal impairment. Pregnancy and lactation. Patient Counselling This drug may cause dizziness and lightheadedness, if affected do not drive or operate machinery. Avoid unnecessary or excessive exposure to sunlight or artificial UV light (e.g. tanning beds, UVA/UVB treatment). If staying outdoors is necessary, use protective measures (e.g. sunscreen, wear loose-fitting clothes). Rest and refrain from exercise as it may increase risk of tendon rupture. Monitoring Parameters Periodically monitor CBC, renal and hepatic function during prolonged therapy. Lactation: Small amounts excreted in breast milk, discontinue drug or do not nurse

Pregnancy-Lactation

Interactions

Additive effect on QT interval prolongation w/ class IA (e.g. quinidine) or class III (e.g. amiodarone) antiarrhythmics and other drugs that prolong QT interval (e.g. erythromycin, TCAs, antipsychotic agents). Increased serum concentrations of theophylline. Reduced absorption w/ oral multivitamins and mineral supplements containing divalent or trivalent cations (e.g. Fe, Zn) and antacids containing Al or Mg, sucralfate, buffered didanosine. Prolonged prothrombin time w/ concomitant coumarin anticoagulant. Increased risk of severe tendon disorders w/ corticosteroids. Concurrent use w/ NSAIDs may increase the risk of CNS stimulation and convulsive seizures.

Adverse Effects

Side effects of Norfloxacin : 1-10% Nausea (4%),Dizziness (3%),Headache (3%),Stomach cramps (3%),Weakness (1%) <1% Abdominal pain,Anorexia,Anxiety,Arthralgia,Arthritis,Ataxia,Back pain,Bitter taste,Cholestatic jaundice,Confusion,Constipation,Depression,Diarrhea,Diplopia,Dysgeusia,Dyspepsia,Dyspnea,Erythema,Exacerbation of myasthenia gravis,Fever,Flatulence,GI bleeding,Heartburn Potentially Fatal: Anaphylaxis, acute renal failure, seizures.

Mechanism of Action

Norfloxacin inhibits the action of DNA gyrase in DNA replication, transcription, repair, recombination and transposition.

Note

Floxus Suspention manufactured by National Healthcare Pvt. Ltd.. Its generic name is Norfloxacin. Floxus is availble in Nepal. Farmaco Nepal drug index information on Floxus Suspention is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Norfloxacin :